Latest Manufacturing Capacity News

Aurora Labs has raised $5.5 million through a strategic placement, partnering with Sovereign Propulsion Systems to advance its drone propulsion technology and expand manufacturing capabilities.

DroneShield is investing $13 million over three years to open a new counter-drone research facility in Adelaide, marking a key step in its global growth and technology development.

VEEM Ltd has secured $14 million through a placement to fuel its expansion in defence manufacturing, including a landmark US$33 million licence agreement with Northrop Grumman. The company is poised to accelerate revenue in the second half of FY26 as it deepens ties with major US defence contractors.

Memphasys Limited is intensifying its commercial push for Felix, an innovative automated sperm separation system for IVF, backed by a landmark Middle East partnership and a fresh capital raise to scale manufacturing and sales.

Zimi Limited has completed its manufacturing transition, fulfilling over $1 million in backorders and restoring product availability in the Australian smart home market.

Sprintex Limited has secured a significant A$16.6 million order to supply integrated control systems for Mest Water’s innovative manure processing units, marking a major step in sustainable agriculture technology in the Netherlands.

Memphasys Limited has secured $0.84 million through a placement and announced a rights issue to raise up to $1.12 million, sharply cutting operating costs to accelerate commercialisation and manufacturing scale-up of its Felix™ bioseparation system.

Wagners Holding Company Limited has launched a A$30 million institutional placement to reduce debt and accelerate growth in its core Construction Materials and Composite Fibre Technologies businesses following a robust FY25 performance.

Wagners Holding Company Limited has secured $30 million through a strongly supported placement to fund growth in its construction materials and composite fibre technologies divisions.

DGL Group Limited has issued a corrected FY25 financial presentation, revealing lower EBITDA and NPAT figures due to operational challenges and restructuring costs. Despite revenue growth, the company faces a modified audit opinion on inventory and outlines strategic cost-cutting and growth investments.

Bioxyne Limited reports a remarkable financial turnaround for FY2025, driven by a 217% revenue surge and its first significant profit, underpinned by expanded medicinal cannabis manufacturing and new supply contracts.

Tissue Repair Ltd reported a 27.3% revenue increase to $3.22 million for FY25, driven by new distribution deals and regulatory progress, while continuing to invest heavily in clinical trials and manufacturing scale-up, resulting in a $4.24 million loss.